The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
DNA Damage-Induced Downregulation of Cdc25C Is Mediated by p53 via Two Independent Mechanisms
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vogelstein, B., Lane, D., & Levine, A. J. (2000) · Nature · doi:10.1038/35042675 · Cited by 6,607
Requirement for p53 and p21 to Sustain G 2 Arrest After DNA Damage
Bunz, F., Dutriaux, A., Lengauer, C., Waldman, T., Zhou, S., Brown, J. P., Sedivy, J. M., Kinzler, K. W., & Vogelstein, B. (1998) · Science · doi:10.1126/science.282.5393.1497 · Cited by 2,803
14-3-3σ is required to prevent mitotic catastrophe after DNA damage
Chan, T. A., Hermeking, H., Lengauer, C., Kinzler, K. W., & Vogelstein, B. (1999) · Nature · doi:10.1038/44188 · Cited by 895
p21/CDKN1A Mediates Negative Regulation of Transcription by p53
Löhr, K., Möritz, C., Contente, A., & Dobbelstein, M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212517200 · Cited by 227
p53 Regulation of G 2 Checkpoint Is Retinoblastoma Protein Dependent
Flatt, P. M., Tang, L. J., Scatena, C. D., Szak, S. T., & Pietenpol, J. A. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.12.4210-4223.2000 · Cited by 161
Borellini, F., & Glazer, R. I. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53046-5 · Cited by 147
Thornborrow, E. C., Patel, S., Mastropietro, A. E., Schwartzfarb, E. M., & Manfredi, J. J. (2002) · Oncogene · doi:10.1038/sj.onc.1205069 · Cited by 132
Self-citationp130/E2F4 Binds to and Represses the cdc2 Promoter in Response to p53
Taylor, W. R., Schönthal, A. H., Galante, J., & Stark, G. R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m005101200 · Cited by 110
Research works printed but not linked: 28
- Chang, 2000, p21Waf1/Cip1/Sdi1-induced growth arrest is associated with depletion of mitosis-control proteins and leads to abnormal mitosis and endoreduplication in recovering cells, Oncogene, 19, 2165, 10.1038/sj.onc.1203573 · DOI · Paper page
- Desai-Yajnik, 1993, The NF-kappa B and Sp1 motifs of the human immunodeficiency virus type 1 long terminal repeat function as novel thyroid hormone response elements, Mol. Cell. Biol, 13, 5057, 10.1128/MCB.13.8.5057 · DOI
- el-Deiry, 1998, Regulation of p53 downstream genes, Semin. Cancer Biol, 8, 345, 10.1006/scbi.1998.0097 · DOI · Paper page
- Espinosa, 2003, p53 functions through stress- and promoter-specific recruitment of transcription initiation components before and after DNA damage, Mol. Cell, 12, 1015, 10.1016/S1097-2765(03)00359-9 · DOI · Paper page
- Gualberto, 1995, p53 and Sp1 interact and cooperate in the tumor necrosis factor-induced transcriptional activation of the HIV-1 long terminal repeat, J. Biol. Chem, 270, 19680, 10.1074/jbc.270.34.19680 · DOI
- Hermeking, 1997, 14-3-3 sigma is a p53-regulated inhibitor of G2/M progression, Mol. Cell, 1, 3, 10.1016/S1097-2765(00)80002-7 · DOI · Paper page
- Krause, 2001, Expression of the cell cycle phosphatase cdc25C is down-regulated by the tumor suppressor protein p53 but not by p73, Biochem. Biophys. Res. Commun, 284, 743, 10.1006/bbrc.2001.5040 · DOI
- Lee, 1999, p53-mediated repression of alpha-fetoprotein gene expression by specific DNA binding, Mol. Cell. Biol, 19, 1279, 10.1128/MCB.19.2.1279 · DOI · Paper page
- Liu, 1997, CDF-1, a novel E2F-unrelated factor, interacts with cell cycle-regulated repressor elements in multiple promoters, Nucleic Acids Res, 25, 4915, 10.1093/nar/25.24.4915 · DOI
- Ludwig, 1996, Differential activation of target cellular promoters by p53 mutants with impaired apoptotic function, Mol. Cell. Biol, 16, 4952, 10.1128/MCB.16.9.4952 · DOI · Paper page
- Manni, 2001, NF-Y mediates the transcriptional inhibition of the cyclin B1, cyclin B2, and cdc25C promoters upon induced G2 arrest, J. Biol. Chem, 276, 5570, 10.1074/jbc.M006052200 · DOI · Paper page
- McCoy, 1995, 12-O-tetradecanoylphorbol-13-acetate activation of the MDR1 promoter is mediated by EGR1, Mol. Cell. Biol, 15, 6100, 10.1128/MCB.15.11.6100 · DOI
- Minc, 1999, The human copper-zinc superoxide dismutase gene (SOD1) proximal promoter is regulated by Sp1, Egr-1, and WT1 via non-canonical binding sites, J. Biol. Chem, 274, 503, 10.1074/jbc.274.1.503 · DOI
- Morgan, 1997, Cyclin-dependent kinases, Annu. Rev. Cell Dev. Biol, 13, 261, 10.1146/annurev.cellbio.13.1.261 · DOI · Paper page
- Murphy, 1999, Transcriptional repression by wild-type p53 utilizes histone deacetylases, mediated by interaction with mSin3a, Genes Dev, 13, 2490, 10.1101/gad.13.19.2490 · DOI · Paper page
- Nilsson, 2000, Cell cycle regulation by the Cdc25 phosphatase family, Prog. Cell Cycle Res, 4, 107, 10.1007/978-1-4615-4253-7_10 · DOI · Paper page
- Ohlsson, 1998, p53 regulates insulin-like growth factor-I (IGF-I) receptor expression and IGF-I-induced tyrosine phosphorylation in an osteosarcoma cell line, Endocrinology, 139, 1101, 10.1210/endo.139.3.5832 · DOI
- Piwnica-Worms, 1999, Cell cycle. Fools rush in, Nature, 401, 535, 10.1038/44029 · DOI
- Resnick-Silverman, 1998, Identification of a novel class of genomic DNA-binding sites suggests a mechanism for selectivity in target gene activation by the tumor suppressor protein p53, Genes Dev, 12, 2102, 10.1101/gad.12.14.2102 · DOI
- Seto, 1992, Wild-type p53 binds to the TATA-binding protein and represses transcription, Proc. Natl. Acad. Sci. USA, 89, 12028, 10.1073/pnas.89.24.12028 · DOI · Paper page
- Shingu, 1994, Overlapping Egr-1 and Sp1 sites function in the regulation of transcription of the mouse thrombospondin 1 gene, J. Biol. Chem, 269, 32551, 10.1016/S0021-9258(18)31669-7 · DOI
- Skerka, 1995, A regulatory element in the human interleukin 2 gene promoter is a binding site for the zinc finger proteins Sp1 and EGR-1, J. Biol. Chem, 270, 22500, 10.1074/jbc.270.38.22500 · DOI
- Sugrue, 1997, Wild-type p53 triggers a rapid senescence program in human tumor cells lacking functional p53, Proc. Natl. Acad. Sci. USA, 94, 9648, 10.1073/pnas.94.18.9648 · DOI · Paper page
- Tang, 1998, Constitutive expression of the cyclin-dependent kinase inhibitor p21 is transcriptionally regulated by the tumor suppressor protein p53, J. Biol. Chem, 273, 29156, 10.1074/jbc.273.44.29156 · DOI
- Taylor, 2001, Regulation of the G2/M transition by p53, Oncogene, 20, 1803, 10.1038/sj.onc.1204252 · DOI · Paper page
- Thornborrow, 1999, One mechanism for cell type-specific regulation of the bax promoter by the tumor suppressor p53 is dictated by the p53 response element, J. Biol. Chem, 274, 33747, 10.1074/jbc.274.47.33747 · DOI
- Thornborrow, 2001, The tumor suppressor protein p53 requires a cofactor to activate transcriptionally the human BAX promoter, J. Biol. Chem, 276, 15598, 10.1074/jbc.M011643200 · DOI
- Zwicker, 1995, Cell cycle regulation of cdc25C transcription is mediated by the periodic repression of the glutamine-rich activators NF-Y and Sp1, Nucleic Acids Res, 23, 3822, 10.1093/nar/23.19.3822 · DOI
Cited by
Blinded by the Light: The Growing Complexity of p53
Vousden, K. H., & Prives, C. (2009) · Cell · doi:10.1016/j.cell.2009.04.037 · Cited by 3,163
Transcriptional control of human p53-regulated genes
Riley, T., Sontag, E., Chen, P., & Levine, A. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2395 · Cited by 1,921
The Cell–Cycle Arrest and Apoptotic Functions of p53 in Tumor Initiation and Progression
Chen, J. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026104 · Cited by 1,222
Census and evaluation of p53 target genes
Fischer, M. (2017) · Oncogene · doi:10.1038/onc.2016.502 · Cited by 971
p53: 800 million years of evolution and 40 years of discovery
Levine, A. J. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-020-0262-1 · Cited by 826
Cell Cycle Regulation by Checkpoints
Barnum, K. J., & O’Connell, M. J. (2014) · Methods in Molecular Biology · doi:10.1007/978-1-4939-0888-2_2 · Cited by 601
Transcriptional Regulation by P53
Beckerman, R., & Prives, C. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a000935 · Cited by 569
Transcriptional regulation by p53: one protein, many possibilities
Laptenko, O., & Prives, C. (2006) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401916 · Cited by 505
Di Agostino, S., Strano, S., Emiliozzi, V., Zerbini, V., Mottolese, M., Sacchi, A., Blandino, G., & Piaggio, G. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.08.013 · Cited by 418
Coordinated Regulation of Cell Cycle Transcripts by p53-Inducible microRNAs, miR-192 and miR-215
Georges, S. A., Biery, M. C., Kim, S.-Y., Schelter, J. M., Guo, J., Chang, A. N., Jackson, A. L., Carleton, M. O., Linsley, P. S., Cleary, M. A., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1846 · Cited by 348
The p53 tumor suppressor participates in multiple cell cycle checkpoints
Giono, L. E., & Manfredi, J. J. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20689 · Cited by 328
Self-citationPersonalized characterization of diseases using sample-specific networks
Liu, X., Wang, Y., Ji, H., Aihara, K., & Chen, L. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw772 · Cited by 317
p53-Dependent Transcriptional Repression of c-myc Is Required for G1 Cell Cycle Arrest
Ho, J. S. L., Ma, W., Mao, D. Y. L., & Benchimol, S. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.17.7423-7431.2005 · Cited by 312
The role of CDC25C in cell cycle regulation and clinical cancer therapy: a systematic review
Liu, K., Zheng, M., Lu, R., Du, J., Zhao, Q., Li, Z., Li, Y., & Zhang, S. (2020) · Cancer Cell International · doi:10.1186/s12935-020-01304-w · Cited by 287
The transcription factor p53: Not a repressor, solely an activator.
Fischer, M., Steiner, L., & Engeland, K. (2014) · Cell Cycle · doi:10.4161/15384101.2014.949083 · Cited by 153
Carvajal, L. A., Hamard, P.-J., Tonnessen, C., & Manfredi, J. J. (2012) · Genes & Development · doi:10.1101/gad.184911.111 · Cited by 151
Self-citationSpurgers, K. B., Gold, D. L., Coombes, K. R., Bohnenstiehl, N. L., Mullins, B., Meyn, R. E., Logothetis, C. J., & McDonnell, T. J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m513901200 · Cited by 114
Müllers, E., Cascales, H. S., Jaiswal, H., Saurin, A. T., & Lindqvist, A. (2014) · Cell Cycle · doi:10.4161/15384101.2015.945831 · Cited by 84
Tabach, Y., Milyavsky, M., Shats, I., Brosh, R., Zuk, O., Yitzhaky, A., Mantovani, R., Domany, E., Rotter, V., & Pilpel, Y. (2005) · Molecular Systems Biology · doi:10.1038/msb4100030 · Cited by 72
Deacetylation of p53 induces autophagy by suppressing Bmf expression
Contreras, A. U., Mebratu, Y., Delgado, M., Montano, G., Hu, C.-A. A., Ryter, S. W., Choi, A. M. K., Lin, Y., Xiang, J., Chand, H., et al. (2013) · Journal of Cell Biology · doi:10.1083/jcb.201205064 · Cited by 48
Metadata
- Authors
- Clair, S. S., Giono, L., Varmeh-Ziaie, S., Resnick-Silverman, L., Liu, W.-J., Padi, A., Dastidar, J., DaCosta, A., Mattia, M., & Manfredi, J. J.
- Venue
- Molecular Cell
- Publisher
- Elsevier BV
- Published
- 2004-12
- Volume
- 16
- Issue
- 5
- Pages
- 725-736
- ISSN
- 1097-2765 (ISSN-L)
- OpenAlex
- W1980669461
- Cited by
- 162
- References
- 8
- FWCI
- 4.26
- Type
- journal article
- Language
- en
- Open access
- bronze
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 3150 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.